Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Croft

Showing results (111-120 of 356) with videos related to

Pageof 36
Sort By:
European Journal of Immunology|February 1, 1983
A monoclonal anti-HLA antibody recognizes a mouse tumor-associated antigenG I Evan, E S Lennox, T Alderson, et al.
Scientific Reports|August 5, 2021
Evaluating the energetics of entrainment in a human-machine coupled oscillator systemRyan T Schroeder, James L Croft, John E A Bertram
Acta Tropica|August 11, 2000
In vitro leishmanicidal activity of monomeric and dimeric naphthoquinonesO Kayser, A F Kiderlen, H Laatsch, et al.
The Journal of Antimicrobial Chemotherapy|February 24, 2016
Drug permeation and barrier damage in Leishmania-infected mouse skinKatrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidateKarin Seifert, Christiane Juhls, Francisco J Salguero, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasisA C Smith, V Yardley, J Rhodes, et al.
Scientific Reports|August 9, 2017
Inhibition of glycogen synthase kinase-3 by BTA-EG<sub>4</sub> reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer's diseaseCara L Croft, Ksenia Kurbatskaya, Diane P Hanger, et al.
Current Opinion in Infectious Diseases|November 14, 2012
Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasisAbeer H A Mohamed-Ahmed, Stephen Brocchini, Simon L Croft
Acta Tropica|August 1, 1992
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1A Gebre-Hiwot, G Tadesse, S L Croft, et al.
Parasitology Research|January 1, 1995
Ribosomes of Leishmania are a target for the aminoglycosidesM Maarouf, F Lawrence, S L Croft, et al.
Pageof 36

Showing results (111-120 of 356) with videos related to

Sort By:
Pageof 36
European Journal of Immunology|February 1, 1983
A monoclonal anti-HLA antibody recognizes a mouse tumor-associated antigenG I Evan, E S Lennox, T Alderson, et al.
Scientific Reports|August 5, 2021
Evaluating the energetics of entrainment in a human-machine coupled oscillator systemRyan T Schroeder, James L Croft, John E A Bertram
Acta Tropica|August 11, 2000
In vitro leishmanicidal activity of monomeric and dimeric naphthoquinonesO Kayser, A F Kiderlen, H Laatsch, et al.
The Journal of Antimicrobial Chemotherapy|February 24, 2016
Drug permeation and barrier damage in Leishmania-infected mouse skinKatrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidateKarin Seifert, Christiane Juhls, Francisco J Salguero, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasisA C Smith, V Yardley, J Rhodes, et al.
Scientific Reports|August 9, 2017
Inhibition of glycogen synthase kinase-3 by BTA-EG<sub>4</sub> reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer's diseaseCara L Croft, Ksenia Kurbatskaya, Diane P Hanger, et al.
Current Opinion in Infectious Diseases|November 14, 2012
Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasisAbeer H A Mohamed-Ahmed, Stephen Brocchini, Simon L Croft
Acta Tropica|August 1, 1992
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1A Gebre-Hiwot, G Tadesse, S L Croft, et al.
Parasitology Research|January 1, 1995
Ribosomes of Leishmania are a target for the aminoglycosidesM Maarouf, F Lawrence, S L Croft, et al.
Pageof 36